Japan Tissue Engineering Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Revenue	1,627	1,723	1,648	1,613	1,712
Other Revenue	555	732	866	419	391
Revenue	2,182	2,455	2,514	2,032	2,103
Revenue Growth (YoY)	-11.12%	-2.35%	23.72%	-3.38%	-6.82%
Cost of Revenue	916	944	823	896	848
Gross Profit	1,266	1,511	1,691	1,136	1,255
Selling, General & Admin	1,236	1,147	1,057	1,221	1,123
Research & Development	497	506	407	573	561
Other Operating Expenses	42	55	59	49	52
Operating Expenses	1,816	1,749	1,546	1,864	1,753
Operating Income	-550	-238	145	-728	-498
Interest & Investment Income	9	2	-	1	2
Currency Exchange Gain (Loss)	-	-	-	-1	-
Other Non Operating Income (Expenses)	4	1	1	2	3
EBT Excluding Unusual Items	-537	-235	146	-726	-493
Gain (Loss) on Sale of Investments	-149	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-	-	-1
Asset Writedown	-75	-10	-130	-	-
Other Unusual Items	30	10	130	-	-
Pretax Income	-731	-235	146	-726	-494
Income Tax Expense	3	20	3	3	3
Net Income	-734	-255	143	-729	-497
Net Income to Common	-734	-255	143	-729	-497
Shares Outstanding (Basic)	41	41	41	41	41
Shares Outstanding (Diluted)	41	41	41	41	41
EPS (Basic)	-18.07	-6.28	3.52	-17.95	-12.24
EPS (Diluted)	-18.07	-6.28	3.52	-17.95	-12.24
Free Cash Flow	-562	-224	78	-771	-328
Free Cash Flow Per Share	-13.84	-5.52	1.92	-18.98	-8.08
Gross Margin	58.02%	61.55%	67.26%	55.91%	59.68%
Operating Margin	-25.21%	-9.70%	5.77%	-35.83%	-23.68%
Profit Margin	-33.64%	-10.39%	5.69%	-35.88%	-23.63%
Free Cash Flow Margin	-25.76%	-9.12%	3.10%	-37.94%	-15.60%
EBITDA	-393	-80	279	-597	-374
EBITDA Margin	-18.01%	-3.26%	11.10%	-29.38%	-17.78%
D&A For EBITDA	157	158	134	131	124
EBIT	-550	-238	145	-728	-498
EBIT Margin	-25.21%	-9.69%	5.77%	-35.83%	-23.68%
Effective Tax Rate	-	-	2.05%	-	-